The Alfred Interventional Radiology Thyroid Ablation Study (Trial Not Registered)

This trial is Currently recruiting

Registration number Trial Not Registered

We are inviting patients who undergo thyroid nodular ablation to allow us to include their coded treatment and outcome information in the study so we can better understand the effectiveness and safety of the procedure over time. Thyroid nodular ablation is a relatively new treatment in Australia, first introduced in April 2021, and there is still limited information about its long-term outcomes. To help strengthen this knowledge, we are conducting the thyroid ablation study (the TArgeT study).

Program & service

This trial is being run with the Radiology & Nuclear Medicine service, and as part of the Radiology & Nuclear Medicine program.

Trial phase

Other

Trial participation type

This trial has been designed for Registry.

Principal investigator

Dr Matthew Lukies

Key inclusion data

Inclusions: Undergo Thyroid Nodular Ablation at Bayside Health; Able to provide informed consent.

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.